Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic LeukemiaWilliam G. Wierda, Anders Österborg, Magdalena Piotrowska et al.|Journal of Clinical Oncology|2010Cited by 587
Optimizing the management of patients with spinal myeloma diseaseSean Molloy, Debo Ademonkun, Isobel Chalmers et al.|British Journal of Haematology|2015Cited by 32